This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 20 and 45
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The purpose of this study is to compare the pharmacokinetics and pharmacodynamics of CJ-12420 after single and multiple dose administration according to H. pylori infection.

Provided treatments

  • Drug: CJ-12420 50mg(HP-)
  • Drug: CJ-12420 100mg(HP-)
  • Drug: CJ-12420 50mg(HP+)
  • Drug: CJ-12420 100mg(HP+)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03009760. The sponsor of the trial is CJ HealthCare Corporation and it is looking for 16 volunteers for the current phase.
Official trial title:
A Phase I , Study to Investigate Pharmacokinetics and Pharmacodynamics of Single and Multiple Dose of CJ-12420 50mg, 100mg in Helicobacter Pylori ?